Biblio Discovery — Demo Discovery Service

35 results for "Shih-Feng Cho"

Showing 1–20 · 0.46 seconds · RSS

  1. Journal Article

    Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

    Yu-Tzu Tai; Shih-Feng Cho; Kenneth C. Anderson

    Frontiers in Immunology, Vol. 9 · 2018 · English · DOAJ Scopus

    Immunomodulatory drugs and monoclonal antibody-based immunotherapies have significantly improved the prognosis of the patients with multiple myeloma (MM) in the recent years. These new classes of reagents target malignant plasma cells (PCs) and further modulate the immune microenvironment, which…

  2. Journal Article

    Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy

    Shih-Feng Cho; Kenneth C. Anderson; Yu-Tzu Tai

    Frontiers in Immunology, Vol. 9 · 2018 · English · DOAJ Scopus

    The approval of the first two monoclonal antibodies targeting CD38 (daratumumab) and SLAMF7 (elotuzumab) in late 2015 for treating relapsed and refractory multiple myeloma (RRMM) was a critical advance for immunotherapies for multiple myeloma (MM). Importantly, the outcome of patients continues to…

  3. Journal Article

    Bispecific antibodies in multiple myeloma treatment: A journey in progress

    Shih-Feng Cho; Tsung-Jang Yeh; Kenneth C. Anderson et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    The incorporation of novel agents and monoclonal antibody-based therapies into the treatment of multiple myeloma (MM) has significantly improved long-term patient survival. However, the disease is still largely incurable, with high-risk patients suffering shorter survival times, partly due to…

  4. Journal Article

    Docetaxel for High-Grade Mucoepidermoid Carcinoma of the Lung

    Hui-Ching Wang; Shih-Feng Cho

    Journal of Cancer Research and Practice, Vol. 2 No. 3 · 2015 · English · DOAJ

    Mucoepidermoid carcinoma is considered to be one of the salivary gland-type cancers, which seldom originate from the lung. Herein, we report a 69-year-old female with primary pulmonary high-grade mucoepidermoid carcinoma. The disease progressed rapidly and reached an unresectable status. We treated…

  5. Journal Article

    Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma

    Hui-Ching Wang; Leong-Perng Chan; Shih-Feng Cho

    Frontiers in Oncology, Vol. 9 · 2019 · English · DOAJ Scopus

    Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with a 5-year mortality rate of ~50%. The development of immunotherapies has improved the survival of patients with HNSCC, but, the long-term prognosis of patients with recurrent or metastatic HNSCC remains poor…

  6. Journal Article

    Large Renal Cell Carcinoma with Multiple Metastases Presenting as Low Back Pain

    Yu-Yin Lin; Chiung-Tang Huang; Shih-Feng Cho

    Journal of Cancer Research and Practice, Vol. 1 No. 1 · 2014 · English · DOAJ

    Renal cell carcinoma (RCC) is a highly lethal genitourinary malignancy due to infrequent early diagnosis, which responds poorly to conventional immune therapy, chemotherapy or radiotherapy in metastatic disease. There have been great advances in the understanding of the molecular mechanisms of RCC…

  7. Journal Article

    Rare Presentation of Prostate Cancer Mimicking Malignant Lymphoma with Generalized Lymphadenopathy

    Yu-Fen Tsai; Shih-Feng Cho; Chun-Chieh Wu et al.

    Journal of Cancer Research and Practice, Vol. 1 No. 1 · 2014 · English · DOAJ

    Prostate cancer typically metastasizes to bones and regional lymph nodes. Generalized lymphadenopathy is a rare manifestation of metastatic prostate cancer. We report a case of prostate cancer in a 65-year-old male with initial presentation of generalized lymphadenopathy and no urinary symptoms…

  8. Journal Article

    Utilizing Advanced Molecular Analysis to Tailor Treatment for Cancer of Unknown Primary Site: A Case Report and Lecture Review

    Tzu-Yu Hsieh; Peir-In Liang; Chun-Chieh Wu et al.

    Journal of Cancer Research and Practice, Vol. 11 No. 3 · 2024 · English · DOAJ

    Cancer of unknown primary site (CUP) presents as metastatic lesions without an identified primary tumor despite extensive evaluation. Because the primary cancer type cannot be determined, there are no standard treatments, leading to challenges in the treatment and suboptimal clinical outcomes…

  9. Journal Article

    HIV-negative disseminated Kaposi’s sarcoma in a Taiwanese patient

    Chiung-Tang Huang; Chao-Sung Chang; Hung-Chune Maa et al.

    Kaohsiung Journal of Medical Sciences, Vol. 27 No. 12 · 2011 · English · DOAJ Scopus

    Kaposi’s sarcoma is a common malignancy associated with HIV/AIDS. Herein, we describe the case of a 26-year-old man who presented with bilateral neck and inguinal lymphadenopathy, a massive tumor on the gum, and a nodule over the left eye. A series of tests, including tumor biopsies, were…

  10. Journal Article Full text

    Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma

    Shih-Feng Cho; Liang Lin; Lijie Xing et al.

    Antibodies, Vol. 6 No. 4 · 2017 · English · DOAJ Scopus

    2015 was a groundbreaking year for the multiple myeloma community partly due to the breakthrough approval of the first two monoclonal antibodies in the treatment for patients with relapsed and refractory disease. Despite early disappointments, monoclonal antibodies targeting CD38 (daratumumab) and…

  11. Journal Article Full text

    Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study

    Shih-Feng Cho; Yi-Hsin Yang; Yi-Chang Liu et al.

    PLOS ONE, Vol. 10 No. 10 · 2015 · English · PLOS Scopus

    Background: The purpose of this study was to investigate the association between previous exposure to statins and the risk of non-Hodgkin lymphoma (NHL). Methods: This nationwide population-based case–control study was conducted using the National Health Insurance Research Database of Taiwan. The…

    Also available at: DOAJ

  12. Journal Article

    Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma

    Shih-Feng Cho; Chin-Chuan Chang; Yi-Chang Liu et al.

    Kaohsiung Journal of Medical Sciences, Vol. 31 No. 3 · 2015 · English · DOAJ Scopus

    The aim of this study was to investigate the role of 2-fluorine-18-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in the initial staging and prediction of bone marrow involvement in patients with newly diagnosed lymphoma. A total of 185 patients with…

  13. Journal Article

    Huge soft tissue PEComa with aggressive lung and bone metastases

    Shih-Hao Tang; Yi-Chang Liu; Hui-Hua Hsiao et al.

    Journal of Cancer Research and Practice, Vol. 4 No. 3 · 2017 · English · DOAJ

    Perivascular epithelioid cell tumors (PEComas) are uncommon mesenchymal tumors characterized by the presence of both myogenic and melanocytic markers, and huge soft tissue PEComas are even rarer. With low prevalence, there has been no common consensus therapy in the past and the treatment response…

  14. Journal Article Full text

    Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study

    Hui-Ching Wang; Pei-Lin Liu; Pei-Chuan Lo et al.

    PeerJ, Vol. 8 · 2020 · English · DOAJ Scopus

    Background This study aimed to analyze the clinical outcomes associated with patients with recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC) who received cetuximab-based chemotherapy in a real-world clinical setting. Methods Clinical data were extracted from RM HNSCC patients…

  15. Journal Article

    Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma

    Shih-Feng Cho; Tsung-Jang Yeh; Hui-Ching Wang et al.

    Scientific Reports, Vol. 14 No. 1 · 2024 · English · DOAJ Scopus

    Abstract The present study aimed to elucidate the prognostic mutation signature (PMS) associated with long-term survival in a diffuse large B-cell lymphoma (DLBCL) cohort. All data including derivation and validation cohorts were retrospectively retrieved from The Cancer Genome Atlas (TCGA)…

  16. Journal Article

    γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

    Hailin Chen; Tengteng Yu; Liang Lin et al.

    Blood Cancer Journal, Vol. 12 No. 8 · 2022 · English · DOAJ Scopus

    Abstract We here defined the impacts of γ-secretase inhibitors (GSIs) on T-cell-dependent BCMA-specific multiple myeloma (MM) cell lysis and immunomodulatory effects induced by bispecific antibodies (BisAbs). GSIs-induced membrane BCMA (mBCMA) accumulation reached near maximum within 4 h and…